WO1997010221A1
(en)
|
1995-09-15 |
1997-03-20 |
Torrey Pines Institute For Molecular Studies |
Synthesis of quinazolinone libraries
|
US5783577A
(en)
|
1995-09-15 |
1998-07-21 |
Trega Biosciences, Inc. |
Synthesis of quinazolinone libraries and derivatives thereof
|
WO1997022594A1
(en)
|
1995-12-15 |
1997-06-26 |
Phytera Symbion Aps |
Combinatorial libraries
|
ATE227293T1
(de)
|
1996-05-15 |
2002-11-15 |
Pfizer |
2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
|
US5952328A
(en)
|
1997-11-12 |
1999-09-14 |
Cephalon, Inc. |
Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
|
US6313113B1
(en)
|
1997-04-15 |
2001-11-06 |
Reddy-Cheminor, Inc. |
Heterocyclic compounds having antidiabetic, hypolipidemic and antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
IL125950A0
(en)
|
1997-09-05 |
1999-04-11 |
Pfizer Prod Inc |
Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
|
US6323208B1
(en)
|
1997-09-05 |
2001-11-27 |
Pfizer Inc |
Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones
|
AU1887999A
(en)
|
1998-01-29 |
1999-08-16 |
Dr. Reddy's Research Foundation |
Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
DE60010448T2
(de)
|
1999-03-17 |
2005-04-07 |
Astrazeneca Ab |
Amid-derivate
|
NZ518480A
(en)
|
1999-10-27 |
2004-02-27 |
Cytokinetics Inc |
Methods and compositions utilizing quinazolinones
|
US6518277B1
(en)
|
2000-04-25 |
2003-02-11 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6730682B2
(en)
|
2000-07-12 |
2004-05-04 |
Pharmacia & Upjohn Company |
Heterocycle carboxamides as antiviral agents
|
PE20021002A1
(es)
|
2001-02-02 |
2002-12-06 |
Takeda Chemical Industries Ltd |
Compuestos heterociclicos condensados
|
DE10145771A1
(de)
|
2001-09-17 |
2003-04-10 |
Bayer Cropscience Ag |
Phthalazinone
|
US6753428B2
(en)
|
2001-11-20 |
2004-06-22 |
Cytokinetics, Inc. |
Process for the racemization of chiral quinazolinones
|
CA2475879A1
(en)
|
2002-02-15 |
2003-08-28 |
Cytokinetics, Inc. |
Synthesis of quinazolinones
|
EP1595870B1
(en)
|
2003-02-20 |
2015-09-23 |
Ajinomoto Co., Inc. |
Process for producing phenylalanine derivative having quinazolinedione skeleton and intermediate for the same
|
WO2005016349A1
(en)
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Methods of inhibiting leukocyte accumulation
|
US20050043239A1
(en)
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
CA2539546C
(en)
|
2003-09-23 |
2010-07-13 |
Merck & Co., Inc. |
Isoquinoline potassium channel inhibitors
|
GB0324790D0
(en)
|
2003-10-24 |
2003-11-26 |
Astrazeneca Ab |
Amide derivatives
|
EP1687306A1
(en)
|
2003-11-14 |
2006-08-09 |
MERCK SHARP & DOHME LTD. |
Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
|
US7939539B2
(en)
|
2003-11-25 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Quinazolinone compounds as anticancer agents
|
US20050239809A1
(en)
|
2004-01-08 |
2005-10-27 |
Watts Stephanie W |
Methods for treating and preventing hypertension and hypertension-related disorders
|
UA83416C2
(en)
|
2004-02-13 |
2008-07-10 |
Баниу Фармасьютикал Ко., Лтд. |
Fused ring 4-oxopyrimidine derivative
|
CA2730540A1
(en)
|
2004-05-13 |
2005-12-01 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
EP1755609A1
(en)
|
2004-05-25 |
2007-02-28 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic cells
|
CA2569406A1
(en)
|
2004-06-04 |
2005-12-22 |
Icos Corporation |
Methods for treating mast cell disorders
|
US20070010537A1
(en)
|
2004-08-20 |
2007-01-11 |
Kazumasa Hamamura |
Fused pyramidine derivative and use thereof
|
WO2006026597A2
(en)
|
2004-08-30 |
2006-03-09 |
Smithkline Beecham Corporation |
Novel compositions and methods of treatment
|
TW200624431A
(en)
|
2004-09-24 |
2006-07-16 |
Hoffmann La Roche |
Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
|
US20060128710A1
(en)
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
CN102516170A
(zh)
|
2004-12-24 |
2012-06-27 |
阿斯利康(瑞典)有限公司 |
酰胺衍生物
|
WO2006089106A2
(en)
|
2005-02-17 |
2006-08-24 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
GB0504019D0
(en)
|
2005-02-26 |
2005-04-06 |
Astrazeneca Ab |
Amide derivatives
|
GB0506147D0
(en)
|
2005-03-24 |
2005-05-04 |
Merck Sharp & Dohme |
Therapeutic agents
|
US7297700B2
(en)
|
2005-03-24 |
2007-11-20 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
GB0509573D0
(en)
|
2005-05-11 |
2005-06-15 |
Merck Sharp & Dohme |
Therapeutic compounds
|
US20090298856A1
(en)
|
2005-05-11 |
2009-12-03 |
Rebecca Elizabeth Brown |
2,3 Substituted fused bicyclic pyrimidin-4(3H)-ones modulating the function of the vanilliod-1receptor (VR1)
|
US7737155B2
(en)
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
US7750015B2
(en)
|
2005-05-17 |
2010-07-06 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
WO2006124490A2
(en)
|
2005-05-17 |
2006-11-23 |
Schering Corporation |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
|
NI200800025A
(es)
|
2005-07-26 |
2009-03-03 |
|
Derivados de isoquinolona sustituidos con piperidinilo en calidad de inhibidores de rho-quinasa
|
ATE521595T1
(de)
|
2005-07-26 |
2011-09-15 |
Sanofi Sa |
Cyclohexylaminisochinolonderivate als rho-kinase- inhibitor
|
GB0516570D0
(en)
|
2005-08-12 |
2005-09-21 |
Astrazeneca Ab |
Amide derivatives
|
ATE540034T1
(de)
|
2005-11-03 |
2012-01-15 |
Portola Pharm Inc |
Ä4-(6-halo-7-substituierte-2,4-dioxo-1,4-dihydr - 2h-chinazolin-3-yl)-phenylü-5-chloro-thiophen-2 yl-sulfonylharnstoffe und relevante formen und verfahren
|
AU2007309708A1
(en)
|
2006-03-13 |
2008-05-02 |
Merck Sharp & Dohme Corp. |
Somatostatin agonists
|
WO2007107469A1
(en)
|
2006-03-20 |
2007-09-27 |
F. Hoffmann-La Roche Ag |
Methods of inhibiting btk and syk protein kinases
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
EP2035386A1
(en)
|
2006-06-19 |
2009-03-18 |
AstraZeneca AB |
Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
|
EP2091947A2
(en)
|
2006-12-20 |
2009-08-26 |
Takeda San Diego, Inc. |
Glucokinase activators
|
US9623021B2
(en)
|
2007-01-22 |
2017-04-18 |
Gtx, Inc. |
Nuclear receptor binding agents
|
WO2009015179A1
(en)
|
2007-07-23 |
2009-01-29 |
Syndax Pharmaceuticals, Inc. |
Novel compounds and methods of using them
|
CN101531638B
(zh)
|
2008-03-13 |
2011-12-28 |
中国科学院广州生物医药与健康研究院 |
用作雌激素相关受体调节剂的化合物及其应用
|
JP2011520969A
(ja)
|
2008-05-19 |
2011-07-21 |
シェーリング コーポレイション |
二環式ヘテロ環誘導体およびgpr119モジュレーターとしてのその使用
|
JP5351254B2
(ja)
|
2008-05-23 |
2013-11-27 |
ノバルティス アーゲー |
キノキサリン−およびキノリン−カルボキシアミド誘導体
|
EP2299814A4
(en)
|
2008-05-27 |
2011-06-15 |
Reviva Pharmaceuticals Inc |
COMPOSITIONS, SYNTHESIS AND METHOD FOR USE OF ANTIPSYCHOTICS ON PIPERAZINE BASIS
|
KR101846029B1
(ko)
|
2008-08-06 |
2018-04-06 |
메디베이션 테크놀로지즈 엘엘씨 |
폴리(adp-리보오스)폴리머라아제 (parp)의 디히드로피리도프탈라지논 억제제
|
MX2011003372A
(es)
|
2008-09-29 |
2011-06-09 |
Sirtris Pharmaceuticals Inc |
Analogos de cromenona como modulares de sirtuina.
|
CA2744937C
(en)
|
2008-11-28 |
2017-02-28 |
Novartis Ag |
Pharmaceutical combination comprising a hsp 90 inhibitor and a mtor inhibitor
|
WO2010065923A2
(en)
|
2008-12-04 |
2010-06-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of cns disorders
|
CA2747158A1
(en)
|
2008-12-16 |
2010-07-08 |
Sirtris Pharmaceuticals, Inc. |
Phthalazinone and related analogs as sirtuin modulators
|
US20110065676A1
(en)
|
2009-06-24 |
2011-03-17 |
Schering Corporation |
Combination therapies comprising par1 antagonists with nar agonists
|
EP2266984A1
(en)
|
2009-06-26 |
2010-12-29 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Pyrido[2,3-d]pyrimidines as Wnt antagonists for treatment of cancer and arthritis
|
CA2770116C
(en)
|
2009-08-10 |
2018-03-13 |
Epitherix, Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
CA2787844C
(en)
|
2010-02-03 |
2019-08-27 |
Biomarin Pharmaceutical Inc. |
Dihydropyridophthalazinone inhibitors of poly(adp-ribose) polymerase (parp) for use in treatment of diseases associated with a pten deficiency
|
WO2011146882A1
(en)
|
2010-05-21 |
2011-11-24 |
Intellikine, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
WO2012011591A1
(ja)
|
2010-07-23 |
2012-01-26 |
武田薬品工業株式会社 |
縮合複素環化合物およびその用途
|
MX2013002295A
(es)
|
2010-09-01 |
2013-05-09 |
Gruenenthal Gmbh |
1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
|
US9029391B2
(en)
|
2011-01-24 |
2015-05-12 |
Viiv Healthcare Uk Limited |
Isoquinoline compounds and methods for treating HIV
|
WO2012166151A1
(en)
|
2011-06-03 |
2012-12-06 |
Biomarin Pharmaceutical Inc. |
Use of dihydropyridophthalazinone inhibitors of poly (adp-ribose) polymerase (parp) in the treatment of myelodysplastic syndrome (mds) and acute myeloid leukaemia (aml)
|
JP2014520776A
(ja)
|
2011-07-04 |
2014-08-25 |
バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー |
植物における非生物的ストレスに対する活性薬剤としての置換されているイソキノリノン類、イソキノリンジオン類、イソキノリントリオン類およびジヒドロイソキノリノン類または各場合でのそれらの塩の使用
|
WO2013012915A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
US20130053365A1
(en)
|
2011-08-30 |
2013-02-28 |
Biomarin Pharmaceutical, Inc. |
Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
|
US20130116241A1
(en)
|
2011-11-09 |
2013-05-09 |
Abbvie Inc. |
Novel inhibitor compounds of phosphodiesterase type 10a
|
JP6207100B2
(ja)
|
2012-12-21 |
2017-10-04 |
ギリアード カリストガ エルエルシー |
イソキノリノンまたはキナゾリノンホスファチジルイノシトール3−キナーゼ阻害剤
|
EA028319B1
(ru)
|
2013-06-14 |
2017-11-30 |
Джилид Калистога Ллс |
Ингибиторы фосфатидилинозитол-3-киназы
|
US9957267B2
(en)
|
2015-07-01 |
2018-05-01 |
Crinetics Pharmaceuticals, Inc. |
Somatostatin modulators and uses thereof
|